APA (7th ed.) Citation

X, R., W, H., X, D., R, M., F, P., X, C., . . . X, T. (2026). Safety, Tolerability, and Pharmacokinetics of GMDTC for Cadmium Poisoning: A Randomized Phase 1a/1b Trial. Clinical pharmacology and therapeutics, 120(1), 160. https://doi.org/10.1002/cpt.70275

Chicago Style (17th ed.) Citation

X, Ren, et al. "Safety, Tolerability, and Pharmacokinetics of GMDTC for Cadmium Poisoning: A Randomized Phase 1a/1b Trial." Clinical Pharmacology and Therapeutics 120, no. 1 (2026): 160. https://doi.org/10.1002/cpt.70275.

MLA (9th ed.) Citation

X, Ren, et al. "Safety, Tolerability, and Pharmacokinetics of GMDTC for Cadmium Poisoning: A Randomized Phase 1a/1b Trial." Clinical Pharmacology and Therapeutics, vol. 120, no. 1, 2026, p. 160, https://doi.org/10.1002/cpt.70275.